Ivantist Treats Glaucoma
Ivantis Microstent Technology
Ivantis MicroStent News & Events

The Hydrus Microstent Ivantis HYDRUS IV United States Clinical Trial

Contact Ivantis Microstent Developers

Dave Van Meter, Chairman, President, and Chief Executive Officer

Dave joined Ivantis as President and CEO in January 2008. Prior to joining Ivantis, Dave held various positions of increasing responsibility in Marketing and General Management throughout his career, most recently at Abbott Vascular, where he began in August 2001...

read more

Randy Alexander, Independent Board Member

Randy is a seasoned senior medical device executive and leader in the ophthalmic industry. Mr. Alexander served as the Chairman of the Board of Directors at Revision OpticsTM from 2011 until 2018...

read more

Ali Behbahani, MD, New Enterprise Associates, Special Partner

Ali joined NEA in 2007 and is a Partner on the healthcare team. He specializes in investments in the biopharmaceutical, medical device, specialty pharmaceutical and healthcare services sectors.

read more

Tara Butler M.D., Ascension Health Ventures

Tara Butler joined AHV in 2002 after completing a residency in obstetrics and gynecology at Washington University in St. Louis. She primarily focuses on...

read more

Ben Gust, GBS Venture Partners

Ben Gust BSc, LLB, GDipAppFin, GAICD joined GBS in 2003 following several years in the legal industry practising as a Solicitor and managing international litigation...

read more

Yoh-Chie Lu, Vertex Healthcare, Venture Partner

Mr. Lu has more than 30 years' experience in the medical industry. He was the founder of Biosensors International Group Ltd, where he was chairman and CEO from its inception until 2008. He retained his leadership position as chairman of the Group from January 2008 until November 2016. Prior to starting Biosensors in 1990, Mr. Lu...

read more

Doug Roeder, Delphi Ventures, General Partner

Doug joined Delphi Ventures as an Associate in 1998 and became a Partner in 2000. His primary investment focus at Delphi is on medical devices and diagnostics...

read more

Peter Kolchinsky, Ph.D., RA Capital Management

Peter Kolchinsky is a founder, Portfolio Manager, and Managing Director at RA Capital Management. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools, and serves as a Board Member for various public and privately held companies...

read more